JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 903 articles

Articles by James Calloway

MercadoLibre's Q4 Margins Narrow as Spending Rises; Shares Under Pressure
Earnings

MercadoLibre's Q4 Margins Narrow as Spending Rises; Shares Under Pressure

MercadoLibre shares slipped following a Q4 profit shortfall, as increased investment in logistics and credit expansion pressured margins despite strong revenue growth.

MELI AMZN SE
Nvidia Stock Drops Despite Record Earnings, Casting Shadow Over AI Rally
Earnings

Nvidia Stock Drops Despite Record Earnings, Casting Shadow Over AI Rally

Nvidia stock declined nearly 4% on Thursday, pulling down major chipmakers and the broader Nasdaq, even after the company reported record quarterly revenue and issued strong forward guidance.

NVDA AMD AVGO META XLK SOXX
Trade Desk Shares Tumble on Cautious Q1 Revenue Outlook, Analyst Downgrades
Earnings

Trade Desk Shares Tumble on Cautious Q1 Revenue Outlook, Analyst Downgrades

The Trade Desk (TTD) shares declined significantly following a first-quarter revenue outlook that disappointed investors, leading to analyst downgrades and a sharp after-hours sell-off.

TTD NVDA GOOGL AMZN
Nu Holdings Shares Tumble Despite Record Q4 Results as Investors Focus on Costs
Earnings

Nu Holdings Shares Tumble Despite Record Q4 Results as Investors Focus on Costs

Nu Holdings shares declined over 8% following its Q4 report, as record revenue and profit were overshadowed by concerns over higher costs and credit risk. The stock extended losses in after-hours trading.

NU
Oracle Shares Dip Amid Analyst Upgrade and Cloud Expansion Focus
Earnings

Oracle Shares Dip Amid Analyst Upgrade and Cloud Expansion Focus

Oracle shares edged lower in Thursday trading despite an upgrade from Oppenheimer, which set a $185 price target. Investors are focused on upcoming fiscal Q3 results and the company's $45–$50 billion funding strategy.

ORCL NVDA
Intuit Shares Surge Ahead of Q2 Earnings, AI Partnership in Focus
Earnings

Intuit Shares Surge Ahead of Q2 Earnings, AI Partnership in Focus

Intuit shares climbed more than 4% in Thursday trading, extending gains ahead of its fiscal second-quarter earnings report. Market attention centers on its new artificial intelligence alliance with Anthropic and early tax-season signals.

INTU
Salesforce Shares Gain on Expanded Buyback, AI Revenue Hits $800M
Earnings

Salesforce Shares Gain on Expanded Buyback, AI Revenue Hits $800M

Salesforce shares advanced Thursday following an increased share repurchase authorization and dividend, with investors focusing on the company's $800M annual AI revenue.

CRM
Resideo Shares Retreat After Sharp Rally as 2026 Outlook and Spin-Off Plan Scrutinized
Earnings

Resideo Shares Retreat After Sharp Rally as 2026 Outlook and Spin-Off Plan Scrutinized

Resideo Technologies shares pulled back in early trading Thursday, giving back a portion of the previous session's 14% surge. The move follows the company's release of its first comprehensive 2026 financial outlook and details on its planned business separation.

REZI HON
Fermi Secures Key Texas Permit for 6-GW Project Matador
Regulation

Fermi Secures Key Texas Permit for 6-GW Project Matador

Fermi Inc. has obtained the final air-quality permit from Texas regulators for its 6-gigawatt Project Matador, allowing major construction to proceed. The stock edged lower premarket as investors also monitor a March 6 securities lawsuit deadline and a March 30 earnings call.

FRMI SIEGY
Figure Technology Shares Rally Ahead of Q4 Earnings Report
Earnings

Figure Technology Shares Rally Ahead of Q4 Earnings Report

Figure Technology Solutions shares advanced premarket Thursday, building on Wednesday's 16.5% surge as investors await fourth-quarter earnings after the close.

FIGR
Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets
Regulation

Hims & Hers Faces SEC Probe, Novo Nordisk Lawsuit as Analysts Cut Targets

Hims & Hers Health shares held steady premarket following disclosures of an SEC probe and a patent lawsuit from Novo Nordisk. Analysts at BTIG and Citi downgraded the stock, citing regulatory risks.

HIMS NVO
TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus
Earnings

TeraWulf Gains Ahead of Q4 Report, Capacity Expansion in Focus

TeraWulf Inc shares edged higher in premarket trading Thursday ahead of its fourth-quarter earnings release, following significant gains earlier in the week. Analysts anticipate $43.55 million in revenue.

WULF